Rare diseases
Investigational molecules
Locations
Back to France478 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
FrancePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
FranceStudy of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
FranceStudy on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction
FranceStudy on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
FranceStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
